A Case of Heparin-Induced Thrombocytopenia That Developed in the Therapeutic Course of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Table 1

Main clinical data of the current case at hospital admission.

Urinalysis
Protein	2+
	7.08 g/gCr
Hematuria	3+
	10–19 HPF
Blood analysis
WBC	9500 μL
Neut	80%
Lym	11.6%
Mono	7.6%
Eos	0.6%
Baso	0.2%
Hb	7.2 g/dL
Plt	431,000 μL
Total protein	4.3 g/dL
Albumin	1.3 g/dL
BUN	37.4 mg/dL
Cr	2.25 mg/dL
UA	6.1 mg/dL
Na	135 mEq/L
K	4.4 mEq/L
Cl	106 mEq/L
AST	15 U/L
ALT	4 U/L
LDH	157 U/L
ALP	153 U/L
γGT	20 U/L
T. bil	0.4 mg/dL
RF	72 IU/mL
ANA (homogeneous)	×20
C3	98 mg/dL
C4	31 mg/dL
CH50	42.8 U/mL
MPO-ANCA	147 U/mL
PR3-ANCA	<1.0 U/mL
Anti-GBM antibody	<2.0 U/mL

WBC, white blood cells; Hb, hemoglobin; Plt, platelet; BUN, blood urea nitrogen; Cr, creatinine; UA, uric acid; Na, sodium; K, potassium; Cl, chloride; AST, aspartate aminotransferase; ALT, alanine aminotransferase; LDH, lactate dehydrogenase; ALP, alkaline phosphatase; γGT, gamma-glutamyl transpeptidase; T. bil, total bilirubin; RF, rheumatoid factor; ANA, antinuclear antibody; C3, complement 3; C4, complement 4; CH50, complement hemolytic activity assay; MPO-ANCA, myeloperoxidase-anti-neutrophil cytoplasmic antibody; PR3-ANCA, proteinase 3-anti-neutrophil cytoplasmic antibody; anti-GBM antibody, anti-glomerular basement membrane antibody.